CASE COMMENTS: CARTELS - EUROPEAN UNION - DEFERRED ENTRY AGREEMENT - FINES

Pay-for-delay: The European Commission fines two pharmaceutical companies €60.5 million for delaying the entry of a generic drug on the market (Teva et Cephalon)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. On 26 November 2020 and following other similar cases (the cardiovascular drug perindopril, the

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • European Court of Justice (Luxembourg)

Quotation

Ludovic Bernardeau, Pay-for-delay: The European Commission fines two pharmaceutical companies €60.5 million for delaying the entry of a generic drug on the market (Teva et Cephalon), 26 November 2020, Concurrences N° 1-2021, Art. N° 99116, p. 120

Visites 34

All reviews